Open AccessAlectinib for Miliary Lung Metastasis in ALK-Positive Lung Adenocarcinoma
Author(s) -
Hironori Satoh,
Yusuke Okuma,
Jumpei Kashima,
Aya Konnno-Yamamoto,
Yasushi Yatabe,
Yuichiro Ohe
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s300229
Subject(s) - alectinib , medicine , lung cancer , adenocarcinoma , lung , pathology , mediastinal lymph node , metastasis , chest radiograph , crizotinib , radiology , cancer , malignant pleural effusion
Miliary pulmonary metastasis characterized by tiny nodules is a rare metastatic pattern in advanced non-small cell lung cancer (NSCLC) and is usually seen in patients harboring an EGFR mutation, and amylase-producing lung cancer is highly uncommon and rarely reported in NSCLC patients who have an EGFR mutation.